Science Explorer Interactive view Map
Company · San Diego · United States

BioAtla (United States)

bioatla.comROR OpenAlex
Research works
26
▲ 817% vs 2013–17
Citations
134
5.1 per fractional work
Top-10% rate
28.2%
record average 16.5%
Open access
24%
world 28%

Not ranked overall: BioAtla (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.13× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 14.30× its world share, 2 worksImmunology and Micro…Chemistry: 1.92× its world share, 0 worksChemistryEngineering: 0.02× its world share, 0 worksEngineeringMathematics: 1.93× its world share, 0 worksMathematicsMedicine: 2.38× its world share, 5 worksMedicineArts and Humanities: 3.14× its world share, 1 worksArts and HumanitiesSocial Sciences: 0.26× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.3×. Every wedge is a field page.

Which keywords describe research at BioAtla (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Fc Receptors, Therapeutic Antibodies, Immunotherapy, Cancer Immunotherapy, Tumor Regression and Tumor Targeting.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Glycosylation6▲ 105×2 topics
  2. Fc Receptors4▲ 170×1 topic
  3. Monoclonal Antibodies4▲ 118×2 topics
  4. Therapeutic Antibodies4▲ 132×1 topic
  5. Cancer Immunotherapy4▲ 109×3 topics
  6. Immunotherapy4▲ 23×6 topics
  7. Tumor Regression4▲ 157×2 topics
  8. Tumor Targeting3▲ 93×3 topics
  9. Arginine Deprivation2▲ 209×1 topic
  10. Bacterial Therapy2▲ 209×1 topic
  11. Cancer2▲ 6.5×5 topics
  12. Immune Regulation2▲ 60×2 topics
  13. Cancer Therapy2▲ 12×7 topics
  14. Tumor Microenvironment2▲ 21×4 topics
  15. CD472▲ 436×1 topic
  16. apoptotic cells2▲ 436×1 topic
  17. Glycans2▲ 77×1 topic
  18. Immune System2▲ 19×1 topic
  19. Chemotherapy2▲ 7.8×4 topics
  20. Cancer Stem Cells1▲ 121×1 topic
  21. Tumor Metastasis1▲ 87×1 topic
  22. CAR T Cells1▲ 104×1 topic
  23. Chimeric Antigen Receptor1▲ 104×1 topic
  24. Immune Checkpoint Blockade1▲ 83×1 topic
  25. Nanoparticles1▲ 3.4×3 topics
  26. PD-1 and PD-L11▲ 83×1 topic
  27. Antigen Presentation1▲ 41×1 topic
  28. Dendritic Cells1▲ 35×1 topic
  29. Immunity1▲ 13×2 topics
  30. Single-Cell1▲ 185×1 topic
  31. Transcriptomics1▲ 185×1 topic

Which research topics does BioAtla (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Cancer Research and Treatments and HER2/EGFR in Cancer Research.

Monoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksCancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksSarcoma Diagnosis and Treatment: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksPhagocytosis and Immune Regulation: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksVaccine Coverage and Hesitancy: 0 fractional worksClick Chemistry and Applications: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyBiotechnologyPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Cancer Research and Treatments Biotechnology 1 works
  4. 4 HER2/EGFR in Cancer Research Oncology 1 works
  5. 5 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  6. 6 Ubiquitin and proteasome pathways Molecular Biology 0 works
  7. 7 Phagocytosis and Immune Regulation Immunology 0 works
  8. 8 Immunotherapy and Immune Responses Immunology 0 works
  9. 9 Vaccine Coverage and Hesitancy Health 0 works
  10. 10 Click Chemistry and Applications Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.8%not open76.2%

World: 28% of research is openly available.

with international co-authors7.9%domestic only92.1%

World: 19% is written across borders.

How has BioAtla (United States)'s research output changed?

Output in 2018–2022 was 817% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.